DFDavis Freimanis

Davis Freimanis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Davis Freimanis has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Delayed Recognition of Thrombotic Thrombocytopenic Purpura Following Platelet Transfusion: A Clinical Pitfall

    by Abdulrahman Al‐Dawoudi, Mujahed Dalain, Daniil Varlamov, Shaghaf Alhallak, Dāvis Freimanis

    Thrombotic thrombocytopenic purpura (TTP) is a rare, life‐threatening thrombotic microangiopathy caused by severe ADAMTS13 deficiency, usually due to autoantibody‐mediated inhibition. Its presentation is heterogeneous and often lacks the classic pentad, leading to diagnostic delays. Neurological symptoms may predominate, masking the underlying hematologic emergency. In our case, a 37‐year‐old previously healthy woman presented with acute headache, speech disturbance, and altered mental status. Despite normal neuroimaging, laboratory tests revealed severe thrombocytopenia and normocytic anemia. Lack of response to erythrocyte and platelet transfusions prompted further evaluation, revealing microangiopathic hemolytic anemia with elevated lactate dehydrogenase, undetectable haptoglobin, indirect hyperbilirubinemia, reticulocytosis, and normal coagulation parameters. A PLASMIC score of 6/7 indicated a high probability of severe ADAMTS13 deficiency. Treatment with high‐dose corticosteroids was initiated immediately, followed by plasma exchange and rituximab. ADAMTS13 activity confirmed severe deficiency at 0.3%, supporting the diagnosis of acquired TTP in the clinical context. The patient achieved rapid remission and complete neurological recovery. This case highlights the importance of early recognition of microangiopathic hemolysis and prompt treatment without waiting for confirmatory ADAMTS13 results to reduce morbidity and mortality.

  • Open Access

    Development and internal validation of an early inpatient risk score for in-hospital mortality in acute pancreatitis: A retrospective cohort study

    by Abdulrahman Al-Dawoudi, Daniil Varlamov, Mujahed Dalain, Nazar Kopytko, Aiga Staka, Davis Freimanis

    Introduction: Early identification of patients at high risk of mortality remains a clinical challenge in acute pancreatitis. Existing prognostic tools are often complex or require repeated assessments, limiting their routine use. We aimed to develop and internally validate an early admission-phase risk score for predicting in-hospital mortality in patients with acute pancreatitis. Methods: We conducted a retrospective cohort study of consecutive adult patients admitted with acute pancreatitis between 2020 and 2024. Acute pancreatitis was defined according to the revised Atlanta criteria. Multivariable logistic regression was used to develop a prediction model for in-hospital mortality using routinely available demographic, clinical, and laboratory variables obtained within the first 24 hours of hospitalization. Missing data were handled using multiple imputation. Model performance was assessed by discrimination and calibration, with internal validation performed using bootstrap resampling and temporal validation conducted in patients admitted during 2023–2024. Results: A total of 1,041 patients were included, of whom 53 (5.1%) died during hospitalization. The final model incorporated age, early multi-organ dysfunction within 24 hours of admission, C-reactive protein, and urea levels. The model showed good discrimination (area under the receiver operating characteristic curve, 0.81) and good agreement between predicted and observed in-hospital mortality probabilities. Bootstrap internal validation showed minimal optimism, and temporal validation in patients admitted during 2023–2024 confirmed stable model performance. A simplified risk score derived from the model stratified patients into low-to-intermediate-risk and high-risk categories, with substantially higher observed in-hospital mortality in the high-risk group. Conclusions: We developed and internally validated an admission-phase risk score for predicting in-hospital mortality in patients with acute pancreatitis using readily available clinical variables. The proposed score may support early inpatient risk stratification within the first 24 hours of hospitalization. However, external validation in independent cohorts across diverse healthcare settings, patient populations, and pancreatitis etiologies is required before broader clinical application.


  • Open Access

    Seasonal variation in hospitalizations for peptic ulcer disease: A five-year retrospective study from Latvia

    by Abdulrahman Al-Dawoudi, Mujahed Dalain, Daniil Varlamov, Nazar Kopytko, Davis Freimanis

    Peptic ulcer disease (PUD) remains a significant global health burden, yet data on seasonal variations in PUD hospitalizations are inconsistent across regions. No studies have assessed seasonal patterns in PUD hospitalizations in Latvia or the broader Baltic region. This study aimed to evaluate whether seasonal factors influence PUD hospitalizations in this temperate-climate setting. We conducted a retrospective cohort study of adult hospitalizations with a primary discharge diagnosis of PUD (ICD-10 codes K25–K28) from 2020 to 2024 at a tertiary care hospital in Riga, Latvia. Seasonal distribution, ulcer subtype, bleeding status, length of stay (LOS), and in-hospital mortality were analyzed using chi-square, Mann–Whitney U, and Kruskal–Wallis tests, as appropriate. Multivariable logistic regression was performed to assess independent predictors of in-hospital mortality. A total of 606 hospitalizations were analyzed (median age: 66 years; 59.1% male). The median LOS was 6 days. Older adults (≥65 years) had higher in-hospital mortality compared with those <65 years (11.7% vs. 3.5%, representing an absolute difference of 8.2%). Seasonal distribution was relatively even: 22.4% in winter, 23.4% in spring, 30.4% in summer, and 23.8% in fall, with a maximum absolute difference of 8.0% between peak and trough seasons; no significant seasonal differences were observed in demographic or clinical characteristics. In multivariable analysis, season was not independently associated with in-hospital mortality (overall Wald p = 0.952), whereas increasing age was independently associated with mortality (adjusted odds ratio [aOR] 1.04 per year; 95% CI 1.02–1.07; p < 0.001). This study provides the first regional evidence from the Baltic area suggesting that seasonal climatic variation does not substantially influence severe PUD hospitalization patterns within a centralized European healthcare system.